Ethical Compliance
SUPRIYA LIFESCIENCE
Sector:
Healthcare
Industry:
Biotechnology
Market Cap Class:
medium
Revenue
1.4%
Debt
0%
Liquidity
8.1%
Revenue
Debt
Liquidity
1.4%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
Other Income | ₹2.28 |
Active pharmaceutical ingredients | ₹557.44 |
Other Operating Revenue | ₹12.93 |
Questionable
INR Crores
Dividend income | ₹0.01 |
Non Compliant
INR Crores
Interest Income | ₹8.35 |
INR Crores
Revenue from Questionable Sources: | ₹0.01 |
Revenue from Non Compliant Sources: | ₹8.35 |
Total: | ₹8.36 |
Total Revenue: | ₹581.01 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹8.36
₹581.01
= 1.4%
compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.